A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide access to continued treatment for subjects who
participated in other Astellas sponsored trials and for whom the investigator feels the
subject may benefit from continued treatment.